Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 8Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 3Supratentorial Neoplasms 2Postoperative Complications 2Meningioma 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1Leiomyoma 1Kidney Neoplasms 1Intraoperative Complications 1

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Standard of Care 1Sodium Chloride 1Self-Help Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Female × Ropivacaine × Clear all
NCT03360214 2025-06-15

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Columbia University

Phase 4 Completed
60 enrolled 11 charts
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡